Reumatolog Ali Theibich ApS: Financial statements 2019
CVR: 39336022
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Reumatolog Ali Theibich ApS (CVR 39336022) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 316,132 and a net result of DKK 70,844 compared with DKK 9,820 the year before. That is an increase of 68.3% compared with the year before. Equity in the 2019 report amounted to DKK 80,665. The solvency ratio was 12.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 316,132
- Profit/Loss
- DKK 70,844
- Equity
- DKK 80,665
- Total Assets
- DKK 646,590
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
On November 25, 2019, the company changed its name from Reumatolog Ali Theibich IVS to Reumatolog Ali Theibich ApS.
Reumatolog Ali Theibich ApS has published its annual report for 2018. Gross profit came to DKK 187,824, and the net result was DKK 9,820.
About Reumatolog Ali Theibich ApS
Reumatolog Ali Theibich ApS is a Danish company of the type Anpartsselskab based in Næstved, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Ali Theibich IVS. The management consists of Ali Ahmed Theibich. The company is owned by Speciallægen Wedian Holding ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,497,333 and a net result of DKK -92,479 compared with DKK 216,289 the year before. Equity in the 2025 report amounted to DKK 1,265,681.
